Leila Raminfar, MD
Family Practice · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Raminfar’s office at (888) 924-1036 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Washington MD.MD.61090031Physician And Surgeon License · since 2020 · expires 2028-04-14ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$18,391
Medicare paid this office $18,391 for 95 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 61 | $6,138 | $80 |
| Long return visit (40+ min) | 15 | $2,318 | $136 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,139 | $165 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,415 | $129 |
| Short return visit (20+ min) | 15 | $867 | $58 |
See all 7 services
| Return visit (30+ min) | 61 | $6,138 | $80 |
| Long return visit (40+ min) | 15 | $2,318 | $136 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,139 | $165 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,415 | $129 |
| Short return visit (20+ min) | 15 | $867 | $58 |
| Administration of influenza virus vaccine | 13 | $421 | $32 |
| Insertion of needle into vein for collection of blood sample | 11 | $95 | $9 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 73 · Women 66% · Also on Medicaid 14% · Health risk score 1.18. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 73% · Coronary heart disease 29% · Chronic kidney disease 27% · Diabetes 25% · Depression 25% · Heart failure 23% · Atrial fibrillation 19% · COPD 16%.
The office billed $67,087, Medicare allowed $23,817 and paid $18,391; for 371 services of 55 kinds; $2,013 of it was for drugs given in the office and $16,377 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 371 | 73 | 1.18 | $67,087 | $18,391 |
| 2023 | 248 | 1,934 | 75 | 1.21 | $194,732 | $64,076 |
| 2022 | 257 | 1,451 | 74 | 1.14 | $161,048 | $50,938 |
| 2021 | 53 | 176 | 74 | 1.29 | $25,343 | $9,071 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 128 | $17,912 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 84 | $10,788 | $128 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,512 | $282 |
| Long return visit (40+ min) | 25 | $3,895 | $130 |
| Short return visit (20+ min) | 42 | $2,291 | $51 |
| Screening mammography | 16 | $2,084 | $130 |
| Influenza vaccine split virus, preservative free | 27 | $1,942 | $72 |
| Sarscv2 vac 30mcg trs-suc im | 14 | $1,799 | $128 |
| Insertion of needle into vein for collection of blood sample | 127 | $1,492 | $8 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $1,475 | $134 |
| Blood test, thyroid stimulating hormone (tsh) | 51 | $1,053 | $16 |
| Blood test, lipids (cholesterol and triglycerides) | 79 | $1,041 | $13 |
| Administration of influenza virus vaccine | 29 | $889 | $31 |
| Screening 3d breast mammography | 16 | $849 | $53 |
| Blood test, comprehensive group of blood chemicals | 66 | $741 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $685 | $18 |
| Administration of pneumococcal vaccine | 18 | $552 | $31 |
| Admn sarscov2 vacc 1 dose | 14 | $549 | $39 |
| Hemoglobin a1c level | 36 | $548 | $9 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 56 | $395 | $6 |
| Prostate cancer screening; prostate specific antigen test (psa) | 11 | $208 | $19 |
| Cyanocobalamin (vitamin b-12) level | 13 | $192 | $15 |
| Thyroxine (thyroid chemical), free | 15 | $133 | $9 |
| Urine microalbumin (protein) level | 18 | $109 | $5 |
| Creatinine level to test for kidney function or muscle injury | 18 | $98 | $5 |
| Manual urinalysis test with examination using microscope, automated | 12 | $47 | $3 |
2022: 26 services
| Return visit (30+ min) | 89 | $10,623 | $85 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 63 | $8,229 | $131 |
| Long return visit (40+ min) | 27 | $3,649 | $126 |
| Short return visit (20+ min) | 62 | $3,586 | $51 |
| Screening mammography | 21 | $2,635 | $125 |
| New patient visit (45+ min) | 14 | $1,308 | $93 |
| 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 11 | $1,183 | $74 |
| Blood test, lipids (cholesterol and triglycerides) | 79 | $1,033 | $13 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 15 | $1,018 | $68 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 22 | $1,009 | $46 |
| Screening 3d breast mammography | 19 | $959 | $50 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 39 | $875 | $18 |
| Blood test, thyroid stimulating hormone (tsh) | 37 | $612 | $16 |
| Administration of influenza virus vaccine | 17 | $506 | $30 |
| Insertion of needle into vein for collection of blood sample | 136 | $485 | $3 |
| Hemoglobin a1c level | 32 | $427 | $9 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 11 | $394 | $25 |
| Prostate cancer screening; prostate specific antigen test (psa) | 18 | $324 | $18 |
| Blood test, comprehensive group of blood chemicals | 30 | $322 | $10 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 16 | $259 | $15 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 39 | $237 | $6 |
| Thyroxine (thyroid chemical), free | 17 | $145 | $9 |
| Urine microalbumin (protein) level | 18 | $104 | $5 |
| Creatinine level to test for kidney function or muscle injury | 18 | $93 | $5 |
| Assessment of emotional or behavioral problems | 13 | $69 | $3 |
| Automated urinalysis test | 12 | $29 | $2 |
2021: 5 services
| Return visit (30+ min) | 21 | $2,197 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,467 | $133 |
| Short return visit (20+ min) | 12 | $753 | $63 |
| Administration of influenza virus vaccine | 11 | $189 | $17 |
| Insertion of needle into vein for collection of blood sample | 20 | $60 | $3 |
Medicaid work
$11,503 in 2024
Medicaid paid $11,503 for 475 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 169 | $11,503 |
| TOBACCO NON-USER | 13 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 122 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 50 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 121 | $0 |
| 2024 | 475 | 5 | 26 | $11,503 |
| 2023 | 210 | 7 | 20 | $3,960 |
| 2022 | 138 | 3 | 19 | $5,873 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 80 | $3,075 |
| Short return visit (20+ min) | 13 | $629 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 52 | $116 |
| Hemoglobin A1C level | 15 | $57 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $49 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 12 | $35 |
| TOBACCO NON-USER | 26 | $0 |
2022
| Return visit (30+ min) | 63 | $2,984 |
| Short return visit (20+ min) | 61 | $2,864 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 14 | $25 |
Drugs they prescribed that Part D paid
$182,734
Pharmacies billed $182,734 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (49 of 2,527) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
2,265 generic and 234 brand-name prescriptions · $182,734 in drug cost · 24 antibiotic prescriptions to 11 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 29 | $40,404 | $1,393 |
| Jardiance | 25 | $25,803 | $1,032 |
| Myrbetriq | 16 | $8,977 | $561 |
| Lantus Solostar | 12 | $5,122 | $427 |
| Atorvastatin | 191 | $2,339 | $12 |
See all 55 drugs
| Ozempic | 29 | $40,404 | $1,393 |
| Jardiance | 25 | $25,803 | $1,032 |
| Myrbetriq | 16 | $8,977 | $561 |
| Lantus Solostar | 12 | $5,122 | $427 |
| Atorvastatin | 191 | $2,339 | $12 |
| Gabapentin | 63 | $1,382 | $22 |
| Levothyroxine | 108 | $1,265 | $12 |
| Rosuvastatin | 104 | $1,202 | $12 |
| Albuterol Sulfate Hfa | 47 | $1,059 | $23 |
| Losartan | 100 | $963 | $10 |
| Omeprazole | 50 | $858 | $17 |
| Amlodipine Besylate | 98 | $821 | $8 |
| Lisinopril | 91 | $718 | $8 |
| Tamsulosin | 32 | $701 | $22 |
| Ezetimibe | 25 | $627 | $25 |
| Metoprolol | 58 | $621 | $11 |
| Estradiol | 13 | $557 | $43 |
| Pantoprazole | 53 | $555 | $10 |
| Metformin Hcl Er | 76 | $529 | $7 |
| Sertraline | 46 | $504 | $11 |
| Ropinirole | 18 | $488 | $27 |
| Duloxetine | 16 | $451 | $28 |
| Famotidine | 17 | $422 | $25 |
| Valsartan | 13 | $385 | $30 |
| Buspirone | 18 | $381 | $21 |
| Trazodone | 42 | $377 | $9 |
| Alendronate | 36 | $358 | $10 |
| Clopidogrel | 24 | $339 | $14 |
| Hydrocodone-Acetaminophen | 12 | $336 | $28 |
| Escitalopram | 19 | $305 | $16 |
| Fluticasone Propionate | 18 | $297 | $16 |
| Citalopram Hbr | 26 | $265 | $10 |
| Potassium Chloride | 15 | $241 | $16 |
| Glipizide Er | 14 | $225 | $16 |
| Spironolactone | 18 | $223 | $12 |
| Torsemide | 12 | $222 | $18 |
| Metoprolol | 31 | $212 | $7 |
| Oxycodone | 14 | $206 | $15 |
| Montelukast | 19 | $203 | $11 |
| Furosemide | 33 | $185 | $6 |
| Finasteride | 21 | $179 | $9 |
| Metformin | 34 | $179 | $5 |
| Fluoxetine | 13 | $175 | $13 |
| Pravastatin | 13 | $166 | $13 |
| Donepezil | 15 | $165 | $11 |
| Meloxicam | 22 | $142 | $6 |
| Losartan-Hydrochlorothiazide | 14 | $119 | $8 |
| Hydrocortisone | 11 | $113 | $10 |
| Amiodarone | 13 | $107 | $8 |
| Hydrochlorothiazide | 23 | $95 | $4 |
| Simvastatin | 16 | $95 | $6 |
| Allopurinol | 11 | $83 | $8 |
| Tizanidine | 12 | $82 | $7 |
| Triamcinolone Acetonide | 11 | $63 | $6 |
| Tramadol | 11 | $16 | $1 |
Year by year
| 2024 | 2,527 | 459 | 2% (49) | 9% | $182,734 |
| 2023 | 4,910 | 640 | 3% (158) | 10% | $485,866 |
| 2022 | 2,705 | 447 | 4% (101) | 10% | $179,030 |
| 2021 | 254 | 87 | None | None | $15,612 |
| 2020 | 138 | 35 | None | None | $5,424 |
| 2019 | 26 | 16 | None | None | $954 |
| 2018 | 16 | None | 0% (0) | None | $559 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 98 drugs
| Ozempic | 28 | $43,972 | $1,570 |
| Jardiance | 25 | $40,505 | $1,620 |
| Lantus Solostar | 31 | $36,254 | $1,169 |
| Basaglar Kwikpen U-100 | 11 | $10,319 | $938 |
| Myrbetriq | 14 | $10,014 | $715 |
| Atorvastatin | 330 | $5,909 | $18 |
| Levothyroxine | 234 | $4,371 | $19 |
| Albuterol Sulfate Hfa | 106 | $3,915 | $37 |
| Gabapentin | 108 | $2,946 | $27 |
| Losartan | 135 | $2,242 | $17 |
| Rosuvastatin | 108 | $2,198 | $20 |
| Potassium Chloride | 70 | $2,124 | $30 |
| Metformin Hcl Er | 110 | $2,042 | $19 |
| Omeprazole | 101 | $1,993 | $20 |
| Metoprolol | 76 | $1,981 | $26 |
| Tamsulosin | 58 | $1,900 | $33 |
| Pantoprazole | 75 | $1,737 | $23 |
| Lisinopril | 175 | $1,626 | $9 |
| Ezetimibe | 26 | $1,483 | $57 |
| Trazodone | 135 | $1,422 | $11 |
| Propranolol Hcl Er | 21 | $1,312 | $62 |
| Amlodipine Besylate | 167 | $1,273 | $8 |
| Bupropion Hcl Sr | 18 | $1,214 | $67 |
| Synthroid | 21 | $1,197 | $57 |
| Valsartan | 28 | $1,184 | $42 |
| Clopidogrel | 43 | $1,181 | $27 |
| Hydrocodone-Acetaminophen | 58 | $1,159 | $20 |
| Duloxetine | 39 | $1,128 | $29 |
| Oxycodone | 49 | $1,048 | $21 |
| Naloxone | 11 | $1,000 | $91 |
| Droplet Pen Needle | 20 | $895 | $45 |
| Valacyclovir | 21 | $886 | $42 |
| Sertraline | 88 | $850 | $10 |
| Amitriptyline | 15 | $782 | $52 |
| Losartan-Hydrochlorothiazide | 19 | $761 | $40 |
| Mirtazapine | 17 | $751 | $44 |
| Escitalopram | 34 | $736 | $22 |
| Ropinirole | 28 | $716 | $26 |
| Estradiol | 30 | $710 | $24 |
| Glipizide Er | 34 | $631 | $19 |
| Furosemide | 72 | $613 | $9 |
| Montelukast | 36 | $587 | $16 |
| Fluoxetine | 29 | $584 | $20 |
| Allopurinol | 34 | $582 | $17 |
| Buspirone | 38 | $556 | $15 |
| Oxybutynin Chloride Er | 16 | $527 | $33 |
| Bupropion Xl | 21 | $520 | $25 |
| Metformin | 45 | $514 | $11 |
| Pregabalin | 21 | $506 | $24 |
| Simvastatin | 47 | $503 | $11 |
| Finasteride | 21 | $488 | $23 |
| Propranolol | 12 | $485 | $40 |
| Fluticasone Propionate | 36 | $477 | $13 |
| Isosorbide Mononitrate Er | 15 | $466 | $31 |
| Citalopram Hbr | 43 | $466 | $11 |
| Pravastatin | 21 | $465 | $22 |
| Acyclovir | 18 | $444 | $25 |
| Tizanidine | 42 | $424 | $10 |
| Alendronate | 35 | $415 | $12 |
| Venlafaxine Hcl Er | 12 | $408 | $34 |
| Hydrocortisone | 14 | $398 | $28 |
| Spironolactone | 20 | $393 | $20 |
| Atenolol | 49 | $393 | $8 |
| Metoprolol | 34 | $330 | $10 |
| Zolpidem | 44 | $324 | $7 |
| Risperidone | 22 | $320 | $15 |
| Clonidine | 11 | $320 | $29 |
| Hydrochlorothiazide | 64 | $316 | $5 |
| Lovastatin | 23 | $304 | $13 |
| Pramipexole Dihydrochloride | 17 | $272 | $16 |
| Triamcinolone Acetonide | 40 | $270 | $7 |
| Triamterene-Hydrochlorothiazid | 17 | $268 | $16 |
| Benazepril | 14 | $267 | $19 |
| Donepezil | 11 | $244 | $22 |
| Hydroxyzine | 13 | $244 | $19 |
| Quetiapine | 19 | $239 | $13 |
| Dilt-Xr | 12 | $239 | $20 |
| Prednisone | 22 | $224 | $10 |
| Ketoconazole | 11 | $204 | $19 |
| Nystatin | 11 | $197 | $18 |
| Methylphenidate Er | 12 | $196 | $16 |
| Lamotrigine | 12 | $177 | $15 |
| Amoxicillin-Clavulanate Potass | 15 | $176 | $12 |
| Cephalexin | 15 | $164 | $11 |
| Cyclobenzaprine | 22 | $163 | $7 |
| Meloxicam | 46 | $160 | $3 |
| Carvedilol | 18 | $150 | $8 |
| Lisinopril-Hydrochlorothiazide | 18 | $145 | $8 |
| Ondansetron Odt | 14 | $131 | $9 |
| Sumatriptan | 17 | $123 | $7 |
| Methocarbamol | 20 | $119 | $6 |
| Ondansetron | 17 | $117 | $7 |
| Fluconazole | 15 | $104 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $86 | $7 |
| Lorazepam | 17 | $75 | $4 |
| Calcitriol | 11 | $69 | $6 |
| Tramadol | 38 | $61 | $2 |
| Alprazolam | 14 | $34 | $2 |
2022: 65 drugs
| Eliquis | 12 | $11,545 | $962 |
| Trelegy Ellipta | 12 | $7,944 | $662 |
| Albuterol Sulfate Hfa | 45 | $2,704 | $60 |
| Ezetimibe | 25 | $2,222 | $89 |
| Gabapentin | 73 | $2,073 | $28 |
| Atorvastatin | 158 | $2,033 | $13 |
| Levothyroxine | 115 | $1,977 | $17 |
| Omeprazole | 93 | $1,659 | $18 |
| Rosuvastatin | 43 | $1,214 | $28 |
| Bupropion Xl | 30 | $1,013 | $34 |
| Pantoprazole | 52 | $969 | $19 |
| Propranolol Hcl Er | 14 | $878 | $63 |
| Metoprolol | 50 | $871 | $17 |
| Potassium Chloride | 48 | $837 | $17 |
| Hydrocodone-Acetaminophen | 38 | $817 | $22 |
| Lisinopril | 83 | $763 | $9 |
| Amitriptyline | 16 | $709 | $44 |
| Valsartan | 31 | $678 | $22 |
| Duloxetine | 23 | $668 | $29 |
| Fluticasone Propionate | 23 | $641 | $28 |
| Trazodone | 74 | $604 | $8 |
| Tizanidine | 29 | $590 | $20 |
| Losartan | 51 | $579 | $11 |
| Tamsulosin | 27 | $507 | $19 |
| Oxycodone | 25 | $502 | $20 |
| Metformin | 49 | $491 | $10 |
| Allopurinol | 26 | $428 | $16 |
| Amlodipine Besylate | 74 | $425 | $6 |
| Topiramate | 24 | $425 | $18 |
| Sertraline | 47 | $405 | $9 |
| Metformin Hcl Er | 40 | $369 | $9 |
| Clopidogrel | 20 | $357 | $18 |
| Escitalopram | 24 | $353 | $15 |
| Glipizide Er | 22 | $341 | $15 |
| Losartan-Hydrochlorothiazide | 11 | $326 | $30 |
| Pramipexole Dihydrochloride | 15 | $314 | $21 |
| Oxycodone-Acetaminophen | 17 | $309 | $18 |
| Hydrocortisone | 20 | $300 | $15 |
| Metoprolol | 29 | $295 | $10 |
| Furosemide | 26 | $276 | $11 |
| Prednisone | 23 | $259 | $11 |
| Buspirone | 22 | $255 | $12 |
| Nortriptyline | 20 | $250 | $12 |
| Pioglitazone | 17 | $238 | $14 |
| Mirtazapine | 16 | $229 | $14 |
| Triamcinolone Acetonide | 34 | $225 | $7 |
| Simvastatin | 32 | $222 | $7 |
| Risperidone | 13 | $218 | $17 |
| Atenolol | 31 | $210 | $7 |
| Valacyclovir | 11 | $185 | $17 |
| Pravastatin | 12 | $166 | $14 |
| Alendronate | 26 | $160 | $6 |
| Fluoxetine | 11 | $111 | $10 |
| Estradiol | 13 | $110 | $8 |
| Hydrochlorothiazide | 33 | $104 | $3 |
| Cyclobenzaprine | 12 | $104 | $9 |
| Lorazepam | 19 | $102 | $5 |
| Zolpidem | 16 | $84 | $5 |
| Meloxicam | 23 | $77 | $3 |
| Sumatriptan | 14 | $73 | $5 |
| Cephalexin | 11 | $66 | $6 |
| Citalopram Hbr | 11 | $60 | $5 |
| Tramadol | 18 | $58 | $3 |
| Glipizide | 11 | $35 | $3 |
| Alprazolam | 13 | $17 | $1 |
2021: 5 drugs
| Albuterol Sulfate Hfa | 12 | $771 | $64 |
| Levothyroxine | 11 | $180 | $16 |
| Atorvastatin | 17 | $136 | $8 |
| Losartan | 13 | $129 | $10 |
| Lisinopril | 11 | $51 | $5 |
2020: 1 drug
| Atorvastatin | 17 | $157 | $9 |
Professional record
- NPI
- 1104323112
- Licence
- WA MD61090031Washington MD.MD.61090031: Active
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-04-07
- NPI last updated
- 2025-04-15
- NPI record certified
- 2025-04-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2901 174th St Ne, Marysville, WA, 98271